Figure 2. Images From Patient 2 at Presentation and After Cessation of Antiprogrammed Cell Death Protein-1/Antiprogrammed Cell Death Ligand-1 (Anti-PD-1/Anti-PD-L1) Therapy.

Note choroidal effusions (A and C) that resolve after agent use cessation (B and D).